Shanghai Angecon Biotechnology Corporation
安集协康
Shanghai Angecon Biotechnology Corporation
Biotech/Healthcare
Anji Xiekang is a developer and manufacturer of cell technology in the medical and health field, engaged in R&D, production, technical services, and marketing in that field, focusing on the development of immune cell therapy and stem cell technologies.
Latest round: Post-IPO (2017)
Source: ChinaBulls — chinabulls.com
Last updated 2017-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.